DHG Pharmaceutical JSC (STC:DHG) Research & Development: ₫0 Mil (TTM As of Mar. 2026)


STC:DHG DHG Pharmaceutical JSC STC:DHG
77 GF Score
Price ₫94,700.00
GF Value ₫113,344.20
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DHG Pharmaceutical JSC Research & Development?

DHG Pharmaceutical JSC STC:DHG 77 Research & Development is ₫0 Mil as of Mar. 2026. GuruFocus rates STC:DHG with a GF Score™ of 77/100 and a GF Value™ of ₫113,344.20 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DHG Pharmaceutical JSC's Research & Development for the three months ended in Mar. 2026 was ₫0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₫0 Mil.

DHG Pharmaceutical JSC  (STC:DHG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DHG Pharmaceutical JSC Research & Development Related Terms

DHG Pharmaceutical JSC Research & Development Historical Data

* Premium members only.

The historical data trend for DHG Pharmaceutical JSC's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DHG Pharmaceutical JSC Research & Development Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DHG Pharmaceutical JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STC:DHG
77GF Score
DHG Pharmaceutical JSC STC:DHG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DHG Pharmaceutical JSC Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₫0 Mil mean?
DHG Pharmaceutical JSC (STC:DHG) has a Research & Development of ₫0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on DHG Pharmaceutical JSC and its competitors.
Is DHG Pharmaceutical JSC's Research & Development too high?
DHG Pharmaceutical JSC's current Research & Development is ₫0 Mil. Overall, DHG Pharmaceutical JSC has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Research & Development compare to ZTS?
DHG Pharmaceutical JSC's Research & Development of ₫0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DHG Pharmaceutical JSC and its competitors. DHG Pharmaceutical JSC's current Research & Development is ₫0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,344.20, compared to a current price of ₫94,700.00 — trading 16.4% below its estimated fair value. The current Research & Development is ₫0 Mil. DHG Pharmaceutical JSC's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Research & Development is ₫0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?

Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued. The current stock price of ₫94,700.00 is trading 16.4% below its estimated GF Value™ of ₫113,344.20. GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.

Key valuation signals for STC:DHG:

  • Research & Development: ₫0 Mil
  • GF Value™: ₫113,344.20 vs. price of ₫94,700.00 (16.4% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DHG Pharmaceutical JSC Business Description

Address 288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
77GF Score

Get the complete analysis for STC:DHG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫94,700.00
Price
₫113,344.20
GF Value